Metropolitan Digital

Men's Weekly


.

The FDA's big gamble on the new Alzheimer's drug

  • Written by C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut
The FDA's big gamble on the new Alzheimer's drugDo the benefits of approving a drug before confirming it works outweigh the potential costs?monkeybusinessimages/iStock via Getty Images Plus

The Food and Drug Administration set off a firestorm of debate when it approved a new drug, aducanumab, for Alzheimer’s disease via an accelerated approval pathway. This decision ignored the...

Read more: The FDA's big gamble on the new Alzheimer's drug

More Articles ...

  1. Here's what I tell teachers about how to teach young students about slavery
  2. Is tax avoidance ethical? Asking on behalf of a few billionaire friends
  3. Senator Warren's wealth tax might prevent billionaires from paying nearly nothing in taxes – but it's probably not constitutional
  4. 535 new fast radio bursts help answer deep questions about the universe and shed light on these mysterious cosmic events
  5. Lack of burial space is changing age-old funeral practices, and in Japan 'tree burials' are gaining in popularity
  6. COVID-19 messages make emergency alerts just another text in the crowd on your home screen
  7. How Joe Biden could increase pressure on Vladimir Putin if their June 16 meeting fails to deter Russia's 'harmful' behavior
  8. A volcanic eruption 39 million years ago buried a forest in Peru – now the petrified trees are revealing South America's primeval history
  9. Protesters marching in Elizabeth City, N.C., over Andrew Brown's killing are walking in the footsteps of centuries of fighters for Black rights
  10. Vacuna contra VIH/SIDA: ¿Por qué no hay una después de 37 años, pero ya tenemos varias para COVID en solo unos meses?
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more